Stock screener

ACRS

Conviction 75HealthcareScan · Thu, Sep 24, 2026
Bullish harami

Aclaris Therapeutics, Inc. (ACRS) closed at $5.38 (+2.28%) on Sep 24, 2026. Its latest daily candle is a bullish harami. Price is below its 50-day and above its 200-day moving average. RSI(14) 43, RS Rating 97, -17.7% from its 52-week high, +86.8% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

ACRS$5.38+2.28%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 3.32M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Aclaris Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.aclaristx.com ↗
Price5.38
Change+2.28%
Gap+0.38%
Rel volume1.81×
Avg volume2.76M
Avg $ vol15.51M
SMA 205.72
SMA 505.78
SMA 2004.40
Price vs 50-6.88%
Price vs 200+22.34%
MA stackmixed
50/200 cross—
Supertrenddown · 6.35
RSI (14)43
MACD hist-0.04
MACD cross—
Stoch %K / %D33 / 38
ADX (14)28
+DI / −DI13 / 27
RSI divergence—
MACD divergence—
ATR %6.44%
ADR %5.88%
52w high6.54
52w low1.81
From 52w high-17.67%
Above 52w low+197.24%
New 52w highNo
SqueezeOff
Bollinger width22.11%
%B0.23
Donchian pos30.45%
Donchian high6.31
Donchian low4.98
AVWAP (52w high)5.67
vs AVWAP high-5.14%
AVWAP (52w low)4.25
vs AVWAP low+26.69%
OBV trendFlat
Chaikin MF (20)0.18
Today vs 20d1.81×
Avg vol (14d)3.32M
Avg vol (20d)2.76M
Avg $ vol (20d)15.51M
Market cap791.93M
RS Rating97 / 99
RS 3m (vs SPY)+5.08%
RS 6m (vs SPY)+33.04%
RS line new highNo
Trend template7/8
Technical rank65.3
1 week-0.37%
1 month-17.67%
3 months+9.57%
6 months+49.86%
1 year+193.99%
YTD+86.81%
P/E-12.20
P/B6.36
P/S101.19
P/FCF-16.77
EPS-0.5300
Div yield—
ROE-52.11%
ROA-36.13%
Debt/Eq0.09
Current3.46
EV/EBITDA-10.32
Gross margin41.41%
Net margin-829.58%
Rev growth-58.19%
EPS growth50.84%
Price target12.00
Target upside123.05%
Analyst ratingBuy
Institutional86.64%
Ent. value783.49M
Revenue1.63M
Net income-21.5M
Gross profit435K
Free cash flow-47.22M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out139.66M
Employees73
ListedWed, Oct 7, 2015
Free float98.38M
Float %81.6%
Short interest15.18M
Days to cover8.7d
Short volume66.8%
Squeeze score86 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.15 vs −$0.16
Last surprise+6.3% beat
Setup gradeA
Conviction75 / 100
Pattern quality—
Tech rank65.3 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish harami

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in ACRS

All disclosures →
No recent disclosed trades by Congress in ACRS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ACRS

InsiderSideShares
Molineaux Christopher P.
Director · Common Stock · 2026-06-05
Exercise11.58K
Humphries William D.
Director · Common Stock · 2026-06-05
Exercise11.58K
MILANO VINCENT
Director · Restricted Stock Units · 2026-06-05
Exercise11.58K
SCHIFF ANDREW N
Director · Common Stock · 2026-06-05
Exercise11.58K
GOWEN MAXINE
Director · Common Stock · 2026-06-05
Exercise11.58K
GOWEN MAXINE
Director · Restricted Stock Units · 2026-06-05
Exercise11.58K
MILANO VINCENT
Director · Common Stock · 2026-06-05
Exercise11.58K
Mehra Anand
Director · Common Stock · 2026-06-05
Exercise11.58K
SCHIFF ANDREW N
Director · Restricted Stock Units · 2026-06-05
Exercise11.58K
Mehra Anand
Director · Restricted Stock Units · 2026-06-05
Exercise11.58K

SEC filings

EDGAR filings in ACRS · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.